BRENT E. ADAMSON, M.D.

Plain English
This study looked at how real-world data (RWD) can be used to understand pain treatments better and improve research practices. The researchers found that using RWD can provide valuable insights that complement traditional clinical trials, as long as the data is analyzed carefully to avoid issues like poor quality and bias. This matters because it can lead to more effective pain management strategies based on actual patient experiences rather than just controlled study settings. Who this helps: This helps patients suffering from pain by shaping better treatment options.

Plain English
This study looked at electronic health records (EHRs) of cancer patients in Germany to check if they accurately represent the larger population and to confirm how well death data is reported. Researchers analyzed records of 1,305 breast cancer patients, 866 with non-small cell lung cancer (NSCLC), and 774 colorectal cancer patients, finding that the characteristics of these groups matched national data closely. The study found that the median survival times were 26 months for breast cancer, 13.4 months for NSCLC, and 21.5 months for colorectal cancer, showing the reliability of EHRs for real-world cancer research. Who this helps: This benefits doctors and researchers studying cancer treatment outcomes.

Plain English
This paper studies the new rules in Europe starting in 2025 that require drug companies to submit evidence about their products quickly, within 100 days. It highlights challenges like figuring out the specific details needed to assess a drug's effectiveness and the tight timeline to gather this evidence. However, it also points to the chance for better cooperation among teams working on clinical, regulatory, and economic evidence, using real-world data to create the evidence needed for approval and evaluation of new medications. Who this helps: Patients who need new treatments and the doctors prescribing them.

Plain English
This study looked into a factor called TRA2B that helps produce a variant of the androgen receptor known as AR-V7 in prostate cancer cells. Researchers found that higher levels of TRA2B were linked to more AR-V7, which is important because AR-V7 contributes to the cancer's resistance to treatment. By targeting TRA2B, they believe it could lead to new treatments for advanced prostate cancer. Who this helps: This helps patients with advanced prostate cancer.

Plain English
This paper proposes the VALID framework — a multi-layered quality assurance system — for evaluating clinical data extracted from medical records by large language models. The framework combines performance benchmarking against human experts, internal consistency checks, replication against established datasets, and demographic subgroup analysis to detect bias. By providing a structured, transparent validation process, VALID aims to establish standards for trustworthy AI-generated real-world evidence in oncology research.

Plain English
This study looked at how neurons, which don’t divide, repair their DNA after being edited by a gene-editing tool called CRISPR. Researchers found that neurons take much longer—up to several weeks—to fix DNA damage compared to stem cells that can divide, which only take a few days. Understanding this process is crucial because it can improve the effectiveness and accuracy of gene therapies for neurological disorders. Who this helps: This benefits patients with genetic neurological diseases.

Plain English
This study looked at how a 12-week online group Pilates program could help people with multiple sclerosis (MS) improve their physical abilities. Out of 22 participants, 16 completed the program, and they showed notable improvements such as a 36% faster time on a 25-foot walk test and a 10% improvement in balance assessments. These findings matter because they indicate that seated Pilates can be a practical way to enhance balance and mobility for people with MS. Who this helps: This benefits patients with multiple sclerosis seeking ways to improve their physical functioning and quality of life.

Plain English
This study focused on improving a method called prime editing, which allows for precise changes in DNA with fewer errors. Researchers created a new platform that can efficiently make these edits and tested it on a large library of about 240,000 edits targeting approximately 17,000 DNA sequences. They found specific harmful genetic changes in 7,996 cases linked to essential genes, which helps in understanding how certain mutations affect gene function. Who this helps: This benefits researchers and doctors working on genetic diseases.

Plain English
This study developed a new technique to identify both natural and synthetic dyes in artworks quickly and accurately. Researchers analyzed a total of 92 dye samples, finding they could detect dyes in very small amounts—some as low as 0.024 parts per million. This method not only helps preserve historical artifacts by revealing how they were dyed but also sheds light on the advancements in dye technology over time. Who this helps: This helps conservators and historians working to preserve and understand artwork.

Plain English
This study investigated how the brains of people with multiple sclerosis (MS) prepare for and initiate movement compared to healthy individuals. Researchers found that people with MS took longer to prepare for movement (delayed brain signals) and showed less neural activity related to movement compared to the healthy group. Specifically, those with MS had slower brain readiness for responding, which can affect their ability to perform tasks quickly and accurately. Who this helps: This research helps patients with MS by highlighting the challenges they face related to movement and reaction times.

Plain English
Researchers developed a new tool called the SLIM-OE ion mobility mass spectrometry system, which can analyze small amounts of proteins more effectively. They found that this system can improve the sensitivity of protein detection by up to 190 times, allowing them to identify 2.3 times more proteins from just 2 nanograms of a specific cell line. This new method not only enhances the ability to detect proteins but also lays the groundwork for better future technologies in protein analysis. Who this helps: This benefits researchers and scientists working in proteomics, helping them get more accurate results from smaller samples.

Plain English
This study looked at how effective the cancer drug pembrolizumab is compared to other treatments for advanced lung cancer in Medicare patients. It found that for certain patient groups, pembrolizumab could improve overall survival by up to 3.6 months, though results varied significantly based on how the data was analyzed. This is important because it can influence how drug prices are negotiated, impacting what patients might pay. Who this helps: This helps patients with advanced lung cancer and their doctors.

Plain English
This study looked at how specific changes in two proteins of the yellow fever vaccine affect its ability to provoke an immune response while remaining safe. Researchers found that certain mutations in the envelope (E) and non-structural 2A (NS2A) proteins make the 17D vaccine better at spreading and kick-starting the body’s defenses, leading to reduced virus activity. This is important because it helps clarify how to make safer, effective vaccines that could be applied to other dangerous viruses. Who this helps: This helps patients by improving vaccine safety and effectiveness.

Plain English
This study looked at whether data on cancer treatment from one country can help predict outcomes for patients in other countries, especially when local information is lacking. Researchers found that adjusted data from the US on advanced non-small cell lung cancer matched survival rates seen in Canada and the UK, suggesting that this kind of non-local data can be useful for decision-making. This insight is important because it allows healthcare organizations to make informed choices even when they don't have enough local data. Who this helps: This benefits patients and healthcare providers in regions with limited local cancer data.

Plain English
This study looked at a new long-acting injectable treatment for HIV prevention, comparing it to the standard daily pill. The research found that if everyone behaves protectively and uses condoms consistently, the new treatment is not cost-effective at about $109,769 per additional healthy year gained. However, if people engage in riskier behaviors, like having more sexual partners without condoms, the treatment becomes much more cost-effective at around $54,536 per additional healthy year gained. It matters because introducing this long-acting option could effectively reduce HIV rates while being financially justifiable, especially in high-risk groups. Who this helps: This benefits patients at risk for HIV, particularly cisgender men who have sex with men and transgender women.

Plain English
This research focused on how human neurons and other non-dividing cells repair DNA damage caused by CRISPR technology. The study found that neurons take longer to fix this damage than dividing cells and use different repair mechanisms. By tweaking these repair processes, researchers can achieve more accurate and effective genome editing, which is important for treating genetic diseases. Who this helps: This benefits patients with genetic diseases by improving potential therapies.

Plain English
This research examined how real-world data from electronic health records in the UK, Germany, and Japan can be used to improve cancer treatment and healthcare decisions. The study found that combining data from these countries can enhance the understanding of cancer care, although challenges exist with accessing and standardizing this data. This is important because it helps researchers and policymakers make better-informed choices that can lead to improved patient outcomes worldwide. Who this helps: This benefits doctors and patients by providing them with more reliable information for cancer treatment decisions.

Plain English
This study looked at how health technology assessment agencies evaluate treatments using evidence from other countries, focusing on whether those findings apply to their own populations. Researchers found that while using local data is preferred, methods to adjust for differences in disease characteristics across countries are underused, making it harder to rely on international evidence. This matters because better use of comparative effectiveness data can lead to more informed healthcare decisions and improved patient outcomes globally. Who this helps: This helps patients and healthcare providers by ensuring treatments are evaluated properly for diverse populations.

Plain English
This study focused on improving a gene-editing technique in mouse embryos by temporarily blocking a DNA repair process. The researchers achieved a 58% success rate in making precise genetic edits with very few mistakes (only 0.5% error rate). This method is important because it allows scientists to create genetically modified mice more effectively, which can help in understanding diseases. Who this helps: This helps researchers in genetic engineering and studies of diseases.

Plain English
This study focused on a specific enzyme called ST3Gal1, which helps create substances that allow prostate cancer cells to evade the immune system. Researchers found that higher levels of ST3Gal1 are linked to less effective immune responses, particularly in tumors treated with a drug called enzalutamide. This is important because it highlights a potential way to improve prostate cancer treatments by targeting how ST3Gal1 influences the immune system's ability to fight cancer. Who this helps: This benefits patients with advanced prostate cancer.

Plain English
This study focused on improving a training program designed to help exercise instructors better understand and support individuals with disabilities. After testing the program with initial participants, the researchers made various updates based on their feedback, which included making the training more interactive and accessible online. These changes aim to ensure that more instructors are equipped to promote health equity and include people with disabilities in their exercise programs. Who this helps: This benefits exercise instructors and individuals with disabilities looking for inclusive fitness opportunities.

Plain English
This study looked at how a specific protein called La can improve a technique known as prime editing, which allows scientists to make precise changes to DNA. The researchers found that when La is present, it significantly enhances prime editing efficiency across different methods and types of edits, achieving up to a 60% increase in editing success rates for certain applications compared to existing methods. This is important because it makes the process of editing genes more effective, which could lead to better treatments for genetic diseases. Who this helps: This benefits researchers and doctors working on gene therapy and genetic engineering.

Plain English
This study focused on improving a genetic editing technique called prime editing, making it more efficient for analyzing many genetic changes at once. The researchers created a system that achieved about 80% accuracy in making precise edits to genes and tested it on a large library of 240,000 genetic targets. They found that certain changes led to negative growth effects in nearly 8,000 genes, which helps scientists understand how specific genetic mutations can cause diseases. Who this helps: This benefits researchers studying genetic disorders and developing targeted therapies.

Plain English
This report created a checklist to help people evaluate if electronic health records (EHR) data can be effectively used in assessing health technologies. The authors found that while EHR data can be very helpful, it also has limitations that affect its accuracy and usefulness. They provided guidance for health technology assessment agencies on how to ensure that the data they use is suitable and reliable so better decisions can be made regarding healthcare. Who this helps: This helps patients, healthcare providers, and health policy makers make more informed decisions.

Plain English
This study looked at a substance called MUC2, which is important for forming the protective mucus in our intestines. Researchers found new details about how MUC2 is structured and how it is released from cells, suggesting that it connects in ways previously not understood, specifically through a new type of bond. This matters because understanding how MUC2 works can help us learn more about gut health and conditions like digestive diseases. Who this helps: This research benefits patients with digestive issues and healthcare providers treating these conditions.

Plain English
This research studied new methods for precise editing of genes, focusing on a technique called CODE that improves upon existing methods. The scientists created two advanced editing tools, CODEMax and CODEMax(exo+), which made efficient changes to human DNA with fewer mistakes—CODEMax made about 90% of intended edits successfully. This matters because it creates safer and more effective ways to correct genetic disorders without damaging the surrounding DNA. Who this helps: This benefits patients with genetic diseases, offering them potential new treatments.

Plain English
This study looked at how certain factors contribute to the production of androgen receptor variants (AR-Vs) in advanced prostate cancer, which are responsible for resistance to current treatments. The researchers found that two specific proteins, MFAP1 and CWC22, are necessary for making these harmful AR-Vs. When they reduced the levels of MFAP1, it not only lowered the amount of AR-Vs produced but also made the cancer cells more sensitive to radiation treatment, suggesting new ways to tackle prostate cancer. Who this helps: This benefits patients with advanced prostate cancer by potentially leading to new treatment strategies.

Plain English
This research studied how groups of stem cells organize themselves into structures that resemble early embryos. The scientists discovered that these stem cells rearrange signaling patterns, specifically Wnt and Nodal activities, to create a front and back axis, which is essential for forming complex shapes. They found that before obvious Wnt signaling appears, some unevenness in Nodal activity lays the groundwork for this organization. Who this helps: This helps researchers and doctors studying embryonic development and regenerative medicine.

Plain English
This study compared the treatment and survival rates of patients with advanced non-small cell lung cancer in the USA and UK. Researchers found that the overall survival rates after starting treatment were similar between the two countries for different types of therapies: about 8 months for chemotherapy, 14 months for immunotherapy, and 20 months for targeted therapy. However, US patients had better survival rates after 12 months when receiving chemotherapy, and they were more likely to receive additional treatments afterward. Who this helps: This research benefits doctors and healthcare policymakers by providing insights into long-term survival rates for lung cancer treatments.

Plain English
This study focused on creating and testing a training program for group fitness instructors to improve their understanding of disability awareness. After completing a 90-minute video training, instructors felt much more confident in adapting fitness classes for people with disabilities, with confidence levels increasing significantly. However, their overall attitudes towards disabilities did not change much after the training. Who this helps: This benefits people with disabilities who want to participate in fitness classes.

Plain English
Researchers looked at how well electronic health records (EHRs) can provide useful information about lung cancer patients when analyzed using machine learning techniques. They studied data from 186,313 patients and found that both machine learning-extracted data and expert-reviewed data gave similar survival rates and treatment effectiveness results, with differences of less than 8%. This is significant because it shows that machine learning can effectively analyze large amounts of health data, making oncology research more efficient and accessible. Who this helps: This helps researchers and doctors by providing better tools to analyze patient data for developing treatment strategies.

Plain English
This study examined how effective it is to give smaller doses of the mpox vaccine during a shortage. Researchers found that if a smaller dose retains at least 40% of the vaccine's effectiveness, it can lead to 13% to 70% fewer infections compared to giving full doses when there are not enough vaccines available. However, if there are enough vaccines to fully cover most high-risk individuals, smaller doses may result in more infections. Who this helps: This research is beneficial for public health officials and the high-risk populations affected by mpox.

Plain English
This research looked at how stem cells grow in a laboratory to form structures similar to early embryos, focusing on how they establish a front and back (anterior-posterior) orientation. The scientists found that a signaling process called Wnt changes from being even across all cells to becoming polarized, which is essential for determining cell positions. Specifically, they discovered that in the first 6 hours, variations in Wnt signals help predict where each cell will end up, influencing their eventual roles. Who this helps: This helps researchers and medical professionals working with stem cells and embryonic development.

Plain English
This research studied the effects of a lutein supplement on people with relapse-remitting multiple sclerosis (MS) over four months. The results showed that participants taking the lutein (12 people) had significant increases in carotenoid levels in their skin and blood compared to those taking a placebo (9 people), with increases in markers like skin carotenoids. While the lutein didn’t directly improve overall cognitive function, improvements in certain attention and memory tasks were linked to the increased carotenoid levels. Who this helps: This research benefits patients with multiple sclerosis who are exploring dietary options to support their health.

Plain English
The MOVE MS program was a study that looked at a group exercise program designed for people with multiple sclerosis (MS) to help improve their symptoms and promote long-term exercise participation. Out of 33 people who started the program, 17 completed it, and while there were slight improvements in exercise participation (from an average score of 14.2 to 16.6), the changes weren’t statistically significant. This study is important because it shows that group exercise programs, even when adapted for online formats, can be a viable option for people with MS to stay active and potentially improve their quality of life. Who this helps: This helps individuals living with multiple sclerosis.

Plain English
This study examined how different genes interact when cells respond to a treatment called PARP inhibitors, which are used in cancer therapy. Researchers analyzed over 147,000 pairs of genes to understand how they work together to fix DNA damage. They found that certain genes have unexpected relationships that affect how well cells repair DNA when treated with PARP inhibitors, laying the groundwork for more research into DNA repair mechanisms. Who this helps: This helps doctors and researchers develop better cancer treatments.

Plain English
This study focused on developing a new method called M3-seq to analyze individual bacteria and their reactions to stress. The researchers found that by using M3-seq, they could examine hundreds of thousands of bacterial cells at once, uncovering rare bacterial populations and how these bacteria respond to stress in different ways. This is important because it helps scientists understand bacterial behavior better, which can lead to improved treatments for infections. Who this helps: This helps researchers and doctors working on bacterial infections and antibiotic resistance.

Plain English
This study focused on how a protein called DNA-PKcs affects the function of androgen receptors (ARs) in advanced prostate cancer, which is driven by abnormal AR signaling. Researchers found that DNA-PKcs plays a crucial role in the production and activity of harmful variants of AR, known as AR-Vs, and that blocking this protein could reduce their activity and slow disease progression. This matters because many current treatments for prostate cancer lose effectiveness due to these AR-Vs, making DNA-PKcs a promising target for developing better therapies. Who this helps: This research helps patients with advanced prostate cancer who have AR-Vs.

Plain English
This study focused on using advanced technology, specifically artificial intelligence (AI), to pull important information from electronic health records (EHRs), which include unstructured data like doctors' notes and lab reports. The researchers found that their AI methods could efficiently extract key clinical information—like cancer diagnosis dates, disease stage, and treatment details—much faster than traditional manual methods, achieving high accuracy. This is significant because it allows for quicker access to vital data that can help enhance cancer research and treatment strategies. Who this helps: This benefits cancer researchers and healthcare providers by giving them better access to patient information.

Plain English
This study looked at how two types of interferon receptors (type I and type III) trigger immune responses that fight viruses. Researchers created special versions of these receptors and found that type I receptors were much better at activating important signaling pathways in cells—specifically, they stimulated these pathways about 2 to 3 times more effectively than type III receptors. Understanding these differences is important because it could improve treatments for viral infections by targeting the right type of interferon for stronger immune responses. Who this helps: This helps patients with viral infections by informing better treatment strategies.

Plain English
This study looked at whether real-world patient data from US cancer treatment centers could be used to help the UK's health authority, NICE, evaluate new cancer drugs. Researchers found that, out of 60 drug assessments, 59 drugs were available in the US before NICE made its recommendations, with an average of 269 patients receiving each therapy during that time. This is important because it shows that there is significant patient data available that could support more timely and informed decisions about new cancer treatments. Who this helps: Patients and healthcare providers involved in cancer treatment.

Plain English
This study looked at how community groups and an academic institution worked together to create fitness programs for people with disabilities, specifically those with multiple sclerosis. Researchers interviewed six partners who had been involved in the program for over two years and found that good communication and planning were crucial for success, while their previous experiences affected their willingness to join the partnership. The findings show that such collaborations can effectively support inclusive fitness opportunities, benefiting not only people with disabilities but also improving community health overall. Who this helps: This helps patients with disabilities and fitness program organizers.

Plain English
This study looked at how many college athletes in the U.S. got COVID-19 and experienced long-lasting effects from it between spring 2020 and fall 2021. Around 9.8% tested positive for COVID-19 in spring 2020, and this number increased to 25.4% during the following academic year. Approximately 4% of those who tested positive went on to develop Long COVID, which includes ongoing health problems weeks after the initial infection. Who this helps: This information is valuable for student athletes, coaches, and medical staff working with college sports.

Plain English
This study looked at how promoting exercise as a medical treatment affects people with multiple sclerosis (MS) and their views on exercise. Researchers analyzed interviews with 22 individuals and found that many feel a constant pressure to exercise, view it as a way to be productive and connect socially, and see it as essential for managing their health. Understanding these perspectives is important for shaping how exercise is recommended to ensure it supports rather than burdens those with MS. Who this helps: This helps patients with multiple sclerosis.

Plain English
This research focuses on how machine learning (ML) can improve health economics and outcomes research (HEOR), which helps understand the value of medical treatments. The study highlights five key areas where ML can make a difference, such as better selecting patient groups for studies and predicting health outcomes more accurately. However, it also points out that not being clear about how ML works can create risks for healthcare providers. A new tool called the PALISADE Checklist was developed to ensure ML practices are both effective and transparent. Who this helps: This benefits researchers and healthcare providers by giving them a reliable framework for using machine learning in their work.

Plain English
This study developed a machine learning tool to help doctors identify cancer patients who might need urgent care within the next 60 days. The research found that in their analysis, 10% of patients were deemed at high risk for emergency department visits, with 76% of those confirmed by doctors as suitable for home care. This is important because it can help prevent emergencies and improve patient care by allowing for timely interventions. Who this helps: This helps patients with cancer and healthcare providers.

Plain English
This study looked at how cells repair serious DNA damage called double-strand breaks (DSBs). Researchers created a new method called Repair-seq, which tested the impact of changing 476 different genes on the way cells fix these breaks, using tools like Cas9 and Cas12a. They found that while some repairs looked similar, they required different genetic resources, which helps us understand DNA repair better and could improve techniques for gene editing. Who this helps: This helps researchers and doctors working on gene therapy and treatments for genetic disorders.